CareFusion recently revealed the takeover of U.K. Medical Limited, a distributor of medical offerings to the private health sector in the U.K. as well as the National Health Service (“NHS”) of that country. U.K. Medical, however, mainly catered to the NHS and distributed many one-time-use medical offerings used in surgery, biopsy, gynecology, obstetrics, drainage, cardiac and other functions. CareFusion did not provide information on the terms of the transaction.
This takeover bolsters CareFusion’s role in the U.K. where it has already created a leadership position for itself in infection prevention and infusion therapy. This acquisition is a natural outcome of the long-standing cooperation between CareFusion and U.K. Medical. With this takeover, CareFusion is in a stronger position to harness its clinical expertise in that country.
U.K. Medical is CareFusion’s fifth takeover, integral to its strategy to grow in the global markets. The U.K.-based distributor enjoyed robust client relationships and clinical know-how on latest medical technologies, including offerings used in acute-care facilities.
U.K. Medical was the only distributor in the U.K. of CareFusion’s Interventional Technologies set up. Furthermore, it has been a major contributor to growth in CareFusion’s Interventional Technologies business.
For its part, U.K. Medical expressed the hope that, as part of CareFusion, it would continue to serve the medical industry of the U.K. with top class medical offerings.
CareFusion is a global company catering to the health care industry with offerings that enable hospitals enhance the safety and quality of care. Following the spin-off of CareFusion a few years ago, the new Cardinal Health (CAH - Analyst Report) and CareFusion businesses began to trade in the bourses.